Galapagos Genomics

Galapagos Genomics

Galapagos Genomics

to get instant updates about 'Galapagos Genomics' on your MyPage. Meet other similar minded people. Its Free!


All Updates

Galapagos Genomics NV was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. The Company later changed its name to Galapagos NV and completed its initial public offering on EuronextAmsterdam and Euronext Brussels in May 2005.

The company uses a technological platform for its research, which is based on adenoviruses to introduce human gene sequences into a wide variety of human cell lines to knock-in or knock-down specific proteins.

Onno van de Stolpe is the CEO of the company.

See also


  • (Dutch)

External links

Read More

No feeds found

wait Posting your question. Please wait!...

No updates available.
No messages found
Tell your friends >
about this page
 Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
 Find your friends
  Find friends on MyPage from